Partnership Expands Global Reach of EarlySense’s Clinically-Proven Continuous Monitoring Technology
RAMAT GAN, Israel, May 15, 2017 /PRNewswire/ --
EarlySense, the market leader in contact-free continuous monitoring solutions, announced today that Shenzhen Lachesis Mhealth, China’s leading intelligent healthcare developer and sister company of leading medical corporation United Imaging Healthcare (UIH), has integrated EarlySense’s InSight™ contactless monitoring technology into its new Intelligent Hospital Ward Solution. The joint platform, designed for general ward staff and patients, will be unveiled at the China International Medical Equipment Fair (CMEF Spring 2017), taking place May 15 - 18 at the National Exhibition and Convention Center in Shanghai (booth #H2-D03).
Lachesis’ Intelligent Hospital Ward Solution provides a complete suite of technologies that enable an advanced and streamlined healthcare flow to deliver more efficient and improved medical services. The platform includes a closed-loop infusion management system, intelligent diagnosis and treatment assistant, nurse digital assistant device, nurse information system, IoT management and a variety of patient monitoring sensors. With the addition of EarlySense, real-time cardiac and respiratory data and notifications will be relayed to the nurses’ station, as well as handheld devices and other remote viewing displays within the facility.
“The need to continuously monitor post-acute care patients is growing, and we are pleased to collaborate with leading smart sensor developer EarlySense on a solution that will prove essential to both patients and healthcare staff across the region,” said Shuangquan Zhu, CEO of Shenzhen Lachesis Mhealth. “Our platform combines wireless sensing technology and advanced analytics to create a seamless, end-to-end solution for safe, cost-effective monitoring of general care patients.”
Placed under a bed mattress, EarlySense’s patented sensor accurately and continuously monitors patient heart rate, respiratory rate and movement without ever touching the patient. Leveraging advanced algorithms that analyze two patient data points per second, the solution assists healthcare teams with early detection of patient deterioration, helping to prevent adverse events, including code blues, patient falls and pressure ulcers.
“We are pleased to collaborate with Lachesis to bring our clinically-proven sensors to China, to help improve patient care and empower health teams,” said Yfat Scialom, VP of International Sales and Marketing of EarlySense. “China is a key market in our global strategy and we look forward to working together to provide best-in-class solutions to one of the world’s largest markets, and to positively impacting healthcare in the region.”
About EarlySense
EarlySense provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense’s patented sensor and advanced algorithms monitor and analyze cardiac, respiratory and motion parameters. Used in hospitals and healthcare facilities worldwide, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues, preventable ICU transfers, patient falls and pressure ulcers.
LIVE by EarlySense is the first home health and sleep monitor powered by medically-proven, contact-free, continuous monitoring technology. The company’s OEM technology is also at the core of wellness and sleep products marketed by international partners including Samsung, Beurer and iFit. EarlySense was founded in 2004 and has offices in Waltham, MA, and Ramat Gan, Israel.
For more information, please visit http://www.earlysense.com and http://www.livebyearlysense.com.
Follow EarlySense on LinkedIn, Twitter and Facebook.
Follow LIVE by EarlySense on Facebook and Twitter
About Lachesis
Founded in 2010, Shenzhen Lachesis Mhealth Co., Ltd (Lachesis) specializes in intelligent healthcare, with a focus on cross-border innovation of intelligent, high-end medical equipment technology. With world-class talent and professional staff from ICT, IOT and the medical industry, Lachesis pioneered the complete solution for Intelligent Ward and Chronic Diseases Management Platform, leveraging intelligent hardware, Bluetooth IOT, medical cloud big data, AI and more. Lachesis has R&D centers in Shenzhen, Shanghai and Wuhan and its sales have reached more than 4,700 hospitals across China. For more information, please visit: http://www.lachesis-mh.com.
Media Contact:
Ellie Hanson
Finn Partners
+1-929-222-8006
ellie.hanson@finnpartners.com
Twitter: @elliesheva
Company Contacts:
Hila Peleg
EarlySense Marcom Manager
+972-54-527-3117
hila.peleg@earlysense.com
Twitter: @EarlySense_Ltd
Christie Xiong
Lachesis Business Director
+86-755-26808505
cuiju.xiong@lachesis-mh.com
SOURCE EarlySense and Lachesis
